Sanigen
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Sanigen provides food-safety testing and sterilisation products that help food manufacturers detect harmful bacteria and viruses in their products.
Its customers are domestic and international food producers that use its diagnostic kits, genomic-analysis services, and sterilisation solutions to manage contamination risks. Listed on KOSDAQ, Korea's tech and small-cap board, the company supplies a full-cycle portfolio spanning molecular diagnostic products, laboratory consumables, and microbial-control agents under its own brands.
Summary is AI-generated and may contain errors · figures from DART filings
Sanigen absorbed a Korean special-purpose acquisition company through a merger, which was the mechanism by which it gained its current listed status on KOSDAQ.
Sanigen in five facts
What does Sanigen do?
Sanigen provides food-safety testing and sterilisation products that help food manufacturers detect harmful bacteria and viruses in their products.
Where is Sanigen listed and in which sector?
Sanigen (Korean name: 세니젠) trades under KRX code 188260 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Consumer Discretionary sector, Consumer Durables.
How large is Sanigen?
Its market capitalisation was US$21.5M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Sanigen's latest annual revenue and operating profit?
For fiscal year 2025, Sanigen reported revenue of US$11.6M, an operating loss of US$3.3M and a net loss of US$4.4M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was down 0.5% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Investor relations (IR) meetingSep 3
- Securities issuance results (voluntary) (third-party placement)
Sanigen completed payment on July 6, 2026 for a third-party-placement rights offering of 637,845 common shares for US$589K, matching the amounts approved by its board on April 15, 2026; the new shares will be listed and are subject to a one-year lock-up from the date of share delivery.
Capital raise · Jul 6 - [Amended] Material event report (rights offering)
Sanigen updated the terms of a private placement (third-party allotment) to raise US$585K, about 3.1% of its market value.
Capital raise · Jun 22 · 3 versions - Change of largest shareholderOwnership change · May 13
- Securities issuance results (voluntary) (third-party placement)Capital raise · May 13
- Material event report (convertible bonds)
Sanigen disclosed convertible bonds to raise US$3.39M, about 17.2% of its market value.
Capital raise · Apr 15 - Material event report (rights offering)
Sanigen disclosed a private placement (third-party allotment) to raise US$6.81M, about 34.4% of its market value.
Capital raise · Apr 14